Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Cocrystal Pharma, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 22 | 22 | 0 |
| Shares | 686.6K | 665.0K | −21.5K (−3.1%) |
| Value | $1.02M | $831.3K | −$191.7K (−18.7%) |
New holders (4)
Institutions that held Cocrystal Pharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Neuberger Berman Group LLC | 31,886 | $39.9K | 0.00% |
| Jane Street Group, LLC | 21,044 | $26.3K | 0.00% |
| Citigroup Inc | 1,053 | $1.32K | 0.00% |
| Barclays PLC | 16 | $20 | 0.00% |
Sold out (4)
Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 40,619 | $60.5K |
| Dimensional Fund Advisors LP | 14,092 | $21.0K |
| Raymond James Financial Inc | 215 | $321 |
| Activest Wealth Management | 1 | $1 |